Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor + Carfilzomib + Dexamethasone in R/R MM
NCT02628704Phase 2Withdrawn
- Sponsor
- Karyopharm Therapeutics Inc.
- Start
- Dec 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in multiple myeloma (MM), sponsored by Karyopharm Therapeutics Inc.. Planned start Dec 2015; status: withdrawn.
02
Drugs
selinexor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02628704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02628704.